Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2006 Dec:27 Suppl 2:134-7.

Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot

Ján Vojtassák  1 , L'ubos Danisovic, Miroslav Kubes, Dusan Bakos, L'ubomír Jarábek, Marcela Ulicná, Milan Blasko
Affiliations
  • PMID: 17159798
Clinical Trial

Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot

Ján Vojtassák et al. Neuro Endocrinol Lett. 2006 Dec.

Abstract

Objectives: This study was performed to test a new technique for treatment of chronic non-healing wound (diabetic ulcer) using autologous biograft composed of autologous skin fibroblasts on biodegradable collagen membrane (Coladerm) in combination with autologous mesenchymal stem cells (MSC) derived from the patient's bone marrow.

Design: The bone marrow aspirate of the patient with diabetic foot was applied directly to the wound and injected into the edges of the wound, finally covered with prepared autologous biograft. The patient received two additional treatments with cultured MSC on day 7 and 17.

Results: The wound showed a steady overall decrease in wound size and an increase in the vascularity of the dermis and in the dermal thickness of the wound bed after 29 days of combined treatment.

Conclusions: Closing and healing of the non-healing diabetic ulcer was achieved by using the given combined therapy.

PubMed Disclaimer

Publication types

LinkOut - more resources